Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $74.87 billion. The enterprise value is $97.05 billion.
Important Dates
The last earnings date was Wednesday, April 22, 2026, before market open.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | Jun 10, 2026 |
Share Statistics
Elevance Health has 217.16 million shares outstanding. The number of shares has decreased by -3.57% in one year.
| Current Share Class | 217.16M |
| Shares Outstanding | 217.16M |
| Shares Change (YoY) | -3.57% |
| Shares Change (QoQ) | -0.63% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 96.18% |
| Float | 216.66M |
Valuation Ratios
The trailing PE ratio is 14.66 and the forward PE ratio is 13.13. Elevance Health's PEG ratio is 3.91.
| PE Ratio | 14.66 |
| Forward PE | 13.13 |
| PS Ratio | 0.37 |
| Forward PS | 0.38 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 16.75 |
| P/FCF Ratio | 11.61 |
| P/OCF Ratio | 9.84 |
| PEG Ratio | 3.91 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.36, with an EV/FCF ratio of 15.05.
| EV / Earnings | 18.51 |
| EV / Sales | 0.48 |
| EV / EBITDA | 11.36 |
| EV / EBIT | 12.42 |
| EV / FCF | 15.05 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.48 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 3.67 |
| Debt / FCF | 4.94 |
| Interest Coverage | 5.52 |
Financial Efficiency
Return on equity (ROE) is 12.09% and return on invested capital (ROIC) is 8.63%.
| Return on Equity (ROE) | 12.09% |
| Return on Assets (ROA) | 3.98% |
| Return on Invested Capital (ROIC) | 8.63% |
| Return on Capital Employed (ROCE) | 9.71% |
| Weighted Average Cost of Capital (WACC) | 6.02% |
| Revenue Per Employee | $2.06M |
| Profits Per Employee | $53,996 |
| Employee Count | 97,100 |
| Asset Turnover | 1.63 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $980.00 million in taxes.
| Income Tax | 980.00M |
| Effective Tax Rate | 15.76% |
Stock Price Statistics
The stock price has decreased by -19.24% in the last 52 weeks. The beta is 0.50, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -19.24% |
| 50-Day Moving Average | 309.71 |
| 200-Day Moving Average | 324.26 |
| Relative Strength Index (RSI) | 71.53 |
| Average Volume (20 Days) | 1,631,388 |
Short Selling Information
The latest short interest is 3.97 million, so 1.83% of the outstanding shares have been sold short.
| Short Interest | 3.97M |
| Short Previous Month | 4.23M |
| Short % of Shares Out | 1.83% |
| Short % of Float | 1.83% |
| Short Ratio (days to cover) | 1.73 |
Income Statement
In the last 12 months, Elevance Health had revenue of $200.42 billion and earned $5.24 billion in profits. Earnings per share was $23.52.
| Revenue | 200.42B |
| Gross Profit | 51.89B |
| Operating Income | 7.82B |
| Pretax Income | 6.22B |
| Net Income | 5.24B |
| EBITDA | 8.54B |
| EBIT | 7.82B |
| Earnings Per Share (EPS) | $23.52 |
Full Income StatementBalance Sheet
The company has $37.07 billion in cash and $31.84 billion in debt, with a net cash position of -$22.19 billion or -$102.16 per share.
| Cash & Cash Equivalents | 37.07B |
| Total Debt | 31.84B |
| Net Cash | -22.19B |
| Net Cash Per Share | -$102.16 |
| Equity (Book Value) | 44.04B |
| Book Value Per Share | 201.97 |
| Working Capital | 21.72B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.61 billion and capital expenditures -$1.16 billion, giving a free cash flow of $6.45 billion.
| Operating Cash Flow | 7.61B |
| Capital Expenditures | -1.16B |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.84B |
| Free Cash Flow | 6.45B |
| FCF Per Share | $29.70 |
Full Cash Flow StatementMargins
Gross margin is 25.89%, with operating and profit margins of 3.90% and 2.62%.
| Gross Margin | 25.89% |
| Operating Margin | 3.90% |
| Pretax Margin | 3.10% |
| Profit Margin | 2.62% |
| EBITDA Margin | 4.26% |
| EBIT Margin | 3.90% |
| FCF Margin | 3.22% |
Dividends & Yields
This stock pays an annual dividend of $6.88, which amounts to a dividend yield of 2.00%.
| Dividend Per Share | $6.88 |
| Dividend Yield | 2.00% |
| Dividend Growth (YoY) | 2.69% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 29.17% |
| Buyback Yield | 3.57% |
| Shareholder Yield | 5.56% |
| Earnings Yield | 7.00% |
| FCF Yield | 8.62% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $379.17, which is 9.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $379.17 |
| Price Target Difference | 9.98% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 11.76% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
